Good point. According to my read of our most recent quarterly...

Good point. According to my read of our most recent quarterly update we have a pre clinical trial net cash outflow of approx $5M per quarter depending on R&D spend.

Will be interesting to see the cash burn in the next quarterly update. Hopefully we will open the IND in a couple weeks and we can either tap the market for a cash top up at a reasonable price (if we need short term cash) or sign a partnership deal once we get our trials underway.

Not sure what the cash burn would be once we start our clinical trials nor how long it will take us to structure and sign a partnership deal. I am not an accountant and no very little about corporate finance.